unknown by unknown
LETTERS TO THE EDITOR
Coagulation abnormalities after Fontan
procedures
To the Editor:
We read with interest the article by Jahangiri and
associates in the June 1997 issue of the Journal (1997;113:
989-93). The concept of coagulation factor abnormalities
in children after Fontan procedures is not new and was
originally described by Cromme-Dijkhuis and associ-
ates1, 2 in 1990 and 1993. In two cross-sectional surveys of
children after Fontan procedures, Cromme-Dijkhuis and
colleagues described multiple coagulation factor abnor-
malities involving both procoagulant and anticoagulant
proteins. The authors noted that these abnormalities
tended to resolve as duration of follow-up lengthened.
However, closer examination of the Cromme-Dijkhuis
articles revealed that the reference ranges used by the
authors were not age-appropriate.3 The majority of the
plasma coagulation factor concentrations in these children
were in fact normal for age. The apparent normalization
with time reflected that with increasing age the children
“grew into” the adult reference ranges that had been
inappropriately applied previously. However, six of 19
patients in the Cromme-Dijkhuis series had higher throm-
bin-antithrombin (TAT) complexes than the age-appro-
priate normal ranges. Increased TAT complexes suggests
a prothrombotic condition, although the mechanism in
this instance remains unknown.
Unfortunately, Jahangiri and associates seem to have
made the same error as Cromme-Dijkhuis and colleagues.
In the Jahangiri article, the authors do not describe the
source of their reference ranges. The normal ranges
quoted are adult reference ranges and are not applicable
to the patient population in question. The lower limit of
normal for children 1 to 5 years of age is as low as 0.4
U/ml, in contrast to the 0.63 U/ml used by the authors.3 It
is likely that multiple age-related normal ranges need to
be applied to the study population. The actual serum
concentrations of the patients are not stated, and it is
likely that many of the children believed to have abnormal
values may be within the appropriate normal ranges. This
would drastically alter the results and conclusions of this
article.
There are many pitfalls to suggesting that patients have
coagulation abnormalities. Testing in the presence of
active thrombus may give false positive results. The meth-
ods used in collecting, processing, and assaying samples all
need rigorous control. The use of accurate normative data
is crucial to the definition of abnormal. The concept of
developmental hemostasis is well established, and pub-
lished normal ranges exist for premature and term infants,
as well as children of all ages.3-5
Whether children who have had the Fontan procedure
have a true prothrombotic condition, either congenital or
acquired, is uncertain. Prospective cohort studies per-
formed with appropriate techniques and compared with
age-appropriate normative data will answer the question.
The current study by Jahangiri and colleagues, because of
major methodologic flaws, does not.
Paul Monagle, MBBS
Maureen Andrew, MD
Hamilton Civic Hospital Research Centre
711 Concession St.
Hamilton, Ontario L9C 3G1, Canada
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Reply to the Editor:
We are aware of the excellent work of Dr. Andrew in
the field of coagulation in childhood. The normal ranges
quoted in the article were provided by the Thrombosis
Research Institute at the Royal Brompton Hospital. Drs.
Monagle and Andrew have quoted a normal range for
children between 1 and 5 years of age. In our study the
median age at the time of the Fontan repair was 6.2 years
and the median time from the Fontan repair to the time of
the study was 4.9 years. The normal range for children 1 to
5 years old, therefore, is not applicable to all the patients
in this group. Considering the normal range for 6- to
10-year-old and 11- to 16-year-old patients published by
Andrew and associates,1 the published results hold (Table
I). We have not noted any recovery of these coagulation
factors.
None of the patients in the study had a history of
thromboembolic episodes, and testing was not performed
in the presence of active thrombus. This eliminates the
chance for false positive results.
Marjan Jahangiri, FRCS
Christopher Lincoln, FRCS
Department of Cardiac Surgery
Royal Brompton Hospital
Imperial College of Science, Technologoy and Medicine
Sydney St.
London SW3 6NP, United Kingdom
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New valid technique for ventricular septal defect
associated with aortic regurgitation
To the Editor:
We read with great interest the article by Yacoub and
associates1 concerning the ideal means of total repair of
ventricular septal defect (VSD) associated with prolapse
of the aortic cusp through a transaortic approach alone.
The authors appear to recognize that current operative
procedures, which have been considered essentially defin-
itive, leave much room for improvement. In supplemental
discussion, they raise questions concerning the validity of
direct closure of the VSD just beneath the pulmonary
valve and the necessity for plication of the prolapsed sinus
of Valsalva for mild aortic regurgitation (AR). On the
basis of our own experience, we support the use of their
new technique.
Concerning the method of VSD closure in the conal
area, especially with a large subpulmonary VSD, Spencer
and associates2 suggested that direct closure produced a
downward displacement of the aortic anulus and destruc-
tion of its commissural support. Kawashima and col-
leagues3 also suggested that it seemed dangerous to
approximate the pulmonic ring to the lower margin of the
defect, because doing so might result in subsequent
tearing of the tissue and recurrence of the defect. Follow-
ing their suggestions, we also performed patch closure for
this type of VSD. However, since 1995 we have performed
direct closure in five patients with a subpulmonary type of
VSD with mild AR. We inserted an interrupted 4-0 or 5-0
polypropylene suture with a pledget from the lower
margin of the VSD to the pulmonary ring to increase
protrusion of the prolapsed cusp by pushing it back and to
improve coaptation of the aortic cusp through the pulmo-
nary artery. As a result, the prolapsing aortic cusp and
mild AR disappeared and no anatomic changes in either
the aortic or pulmonic anulus were found on follow-up
echocardiography. Furthermore, postoperative murmur,
which appears sometimes to result from the use of a patch,
was detected in none of the patients.
Recently, the incidence of moderate or more severe AR
associated with this type of VSD has markedly decreased,
because patients are immediately referred for closure of
the VSD when progression of prolapse of the aortic cusp
or the occurrence of AR is detected. Consequently, the
number of patients needing valvuloplasty has decreased.
However, the problem of degeneration of the repaired
aortic valve has been considered on long-term follow-up
for patients who have undergone excessive valvuloplasty
for AR. To prevent direct excessive manipulation of the
cusps to the repair, we4 have also used aortoplasty (plica-
tion of the aorta) to achieve protrusion of the cusp when
coaptation is not improved after plication of the prolapsed
cusp. Taking into consideration the long-term results,
Yacoub’s plication maneuver also seems likely to improve
coaptation of the cusps without the need to touch them,
especially in patients with moderate or severe AR.
Kouchi Hisatomi, MDa
Akira Taira, MDa
Shouzo Oku, MDb
Yukinori Moriyama, MDa
Second Department of Surgerya
Pediatric Departmentb
Faculty of Medicine
Kagoshima University
8-35-1 Sakuragaoka
Kagoshima 890, Japan
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Reply to the Editor:
My colleagues and I read with interest the comments by
Hisatomi and his colleagues. We agree that direct closure
of the ventricular septal defect in this syndrome does not
produce abnormal displacement of the aortic anulus,
“destruction of the commissural support,” or any undue
tension on the lower margin of the defect. The reason is
that one of the basic abnormalities in the syndrome is the
presence of excessive redundant tissue produced by dila-
tation of the aortic sinus, which results in downward and
Table I. Coagulation factors in 15 patients who had
protein C and protein S levels below the normal
range
Age (yr)
1-5 6-10 11-16
No. of patients 4 8 3
Protein C (%) 42 46 52
47 39 48
33 49 57
30 46
51
44
32
39
No. of patients 1 2 1
Protein S (%) 52 47 46
39
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